Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.495
-0.075 (-2.92%)
Jul 21, 2025, 12:21 PM - Market open
Taysha Gene Therapies Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$8.17
Upside
+227.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +220.64% | Jul 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +220.64% | Jul 1, 2025 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +220.64% | Jun 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +340.88% | Jun 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $6 → $8 | Strong Buy | Reiterates | $6 → $8 | +220.64% | Jun 2, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +140.48% | May 29, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +260.72% | May 29, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +260.72% | May 16, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +100.40% | Apr 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +180.56% | Apr 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.48% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.48% | Feb 27, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +180.56% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.48% | Jan 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +220.64% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +180.56% | Nov 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.